GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of MHRA threads, summarised so you do not have to read them — 61 comments in the full submission. View in context.
1.1k
c/glp1uk·submitted 5 months ago by u/gradient_goblin

three years of MHRA threads, summarised so you do not have to read them

Questionbranch of 6 comments

The title is the argument: three years of MHRA threads, summarised so you do not have to read them. Here is the rest of it. Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across. Scotland, Wales and…

Read the full submission and all 61 comments →

This branch

6 comments, started 5 months ago
u/nadia_trevino112 points·5 months ago

Disagree. That is the pathway in one ICB and it does not generalise even to the next one over.

replysharereportpermalink
u/boots_or_bust0 points·5 months ago

Disagree.

nadia_trevino is right that the two routes are separate. A private prescription does not move you up the list.

replysharereportpermalink
u/kavya_kravchenko0 points·5 months ago

England, Scotland, Wales and Northern Ireland are four different pathways

replysharereportpermalink
u/ipamorelin_i-31 points·5 months ago

BMI thresholds vary by ICB and by year

replysharereportpermalink
u/nadia_trevino1 point·5 months ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
[removed]1 point·5 months ago

[removed by moderator]

replysharereportpermalink

← back to the whole thread

About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/glp1uk
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/nhs_waitlist_nu/boots_or_bustu/lane_watcheru/ireland_drugs_pay
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →